STAT

MAY 5, 2023

A new study sheds light on what may be causing very rare cases of heart inflammation in young men after receiving an mRNA Covid vaccine. Early hypotheses as to what was driving the heart inflammation, called myocarditis , included an allergic response to the vaccine, vaccine-induced antibodies, or an autoimmune response in which the immune system attacks the body’s own healthy tissue by mistake.

Vaccines 361

Vaccines Immunity Immunization 361

PharmaVoice

MAY 5, 2023

The biotech CEO is bullish on the company’s pioneering T cell receptor platform and innovating new immunology-based treatments.

130

130

STAT

MAY 5, 2023

The ending of the public health emergency for Covid-19 will force the Centers for Disease Control and Prevention to cut back on the data it collects to analyze how much illness the SARS-CoV-2 virus is causing in the future, the CDC announced Friday. But some of the data metrics the CDC will no longer be able to collect are of lesser value now than they were at earlier points in the pandemic, agency officials explained in a press briefing Thursday in advance of Friday’s release of two arti

281

281

Safe Biologics

MAY 5, 2023

On April 30th, the Generics and Biosimilar Initiative (GaBI) published a meeting report on a 2-hour webinar entitled “Non-Medical Switching of Biologicals and Biosimilars: Canada, Europe, and the US”, hosted July 20th, 2022 by ASBM and GaBI. During the webinar, academic clinicians, patient advocates, policymakers and regulatory experts from Canada and the US shared their experience and knowledge.

Biosimilars 100

Biosimilars 100

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

MAY 5, 2023

The World Health Organization ended the Covid-19 global health emergency on Friday, saying it was time for countries to transition from treating Covid as an emergency to dealing with it as a disease that is here to stay. The decision was made on the advice of a panel of independent experts, the so-called Covid-19 emergency committee, which met Thursday.

264

264

Safe Biologics

MAY 5, 2023

On April 30th, the Generics and Biosimilar Initiative (GaBI) published a meeting report on a 2-hour webinar entitled “Non-Medical Switching of Biologicals and Biosimilars: Canada, Europe, and the US”, hosted July 20th, 2022 by ASBM and GaBI. During the webinar, academic clinicians, patient advocates, policymakers and regulatory experts from Canada and the US shared their experience and knowledge.

Biosimilars 100

Biosimilars 100

BioPharma Dive

MAY 5, 2023

Higher-than-expected sales of the geographic atrophy therapy Syfovre pushed shares in Apellis higher, and could add to speculation about a takeover.

116

116

STAT

MAY 5, 2023

“I cannot tell you how much it means to me that my extra chromosome might lead to the answer to Alzheimer’s,” Frank Stephens, a self-advocate with Down syndrome, told Congress in 2017. His heart-wrenching comment, which was followed by thunderous applause and a standing ovation, got it exactly right. People with Down syndrome have an extra copy of the 21st chromosome — the chromosome on which the gene that codes for amyloid precursor protein is located.

243

243

BioPharma Dive

MAY 5, 2023

The biotech is the latest startup to capitalize on rising investor interest in targeted drugs that use radioisotopes to destroy tumors.

122

122

STAT

MAY 5, 2023

Jennifer Doudna may be just months away from seeing the first CRISPR-based therapy gain approval, but sitting on stage Thursday, the Nobel laureate sounded as ambitious and hungry as ever. “How do we make sure that a technology like CRISPR — you know, no offense intended — is not just going to make a few people rich?” she told a room full of executives and investors at the STAT Breakthrough Summit in San Francisco, “but it’s going to actually have a broa

230

230

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

The Honest Apothecary

MAY 5, 2023

Do you find yourself frequently needing to remind your boss about something they were supposed to do? Or are you, perhaps, frequently guilty of dropping the ball on a piece of a project that you needed to get done? Maybe your particular struggle is in responding to requests for information or feedback. Or do people need to reach out to you 2, 3, 4 times or more to try and get your input or advice?

Documentation 100

Documentation 100

STAT

MAY 5, 2023

The director of the Centers for Disease Control and Prevention, Rochelle Walensky, announced Friday that she will leave the agency at the end of June. “I took on this role with the goal of leaving behind the dark days of the pandemic and moving CDC — and public health — forward into a much better and more trusted place,” Walensky said in an email to her staff, a copy of which was obtained by STAT.

226

226

Pharmaceutical Technology

MAY 5, 2023

Sanofi Canada has received approval from Health Canada for its Dupixent (dupilumab injection) to treat eosinophilic esophagitis (EoE) in adults and in adolescent patients aged 12 years and above. It is being jointly developed by Sanofi and Regeneron under a global collaboration agreement. In Canada, it is commercialised by Sanofi Canada and Regeneron Canada.

98

98

STAT

MAY 5, 2023

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them.  Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

213

213

The Pharmacist

MAY 5, 2023

The number of repeat prescriptions ordered via the NHS app has increased by 92% in the last year, according to new figures released by NHS England (NSHE). And patients have been reminded that they can use the app to order repeat prescriptions during bank holidays. Over 500,000 repeat prescriptions are booked through the NHS App […] The post Repeat prescription orders via NHS App nearly doubles in a year appeared first on The Pharmacist.

96

96

STAT

MAY 5, 2023

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. And our agenda is quite busy. We are returning to the campus after a stint on the road, but then planning to collect our shortest person from an institution of higher learning. Our official mascot will have a friend arrive for an extended sleepover.

Vaccines 207

Vaccines 207

The Pharmacist

MAY 5, 2023

GPs around the country have added their calls for a funded minor ailments scheme through community pharmacy as they say they are seeing more and more patients coming to ask for prescriptions for over-the-counter (OTC) medicines for minor conditions because they simply have no money to buy them. Earlier this week, The Pharmacist reported that the cost-of-living […] The post GPs join calls for minor ailments scheme appeared first on The Pharmacist.

Community Pharmacies 95

Community Pharmacies 95

STAT

MAY 5, 2023

This week, the “Godfather of AI” Geoffrey Hinton made news when he left Google and aired his concerns about how powerful artificial intelligence has become. In the last few months alone, ChatGPT has fueled frenzied efforts to use AI in nearly every industry — including health care. “In the last 10 years we’ve seen very steady acceleration of the technology,” said Suchi Saria, CEO and founder of Bayesian Health, at the STAT Breakthrough Summit in San Fran

Hospitals 200

Hospitals 200

European Pharmaceutical Review

MAY 5, 2023

Researchers have developed a physics-enhanced autocorrelation-based estimator (PEACE) machine learning algorithm that can extract the particle size distribution (PSD) of a pharmaceutical powder surface from its laser speckle. The method provides a real-time, non-invasive, far-field optical probe to monitor particle size distributions quantitatively.

Pharmaceutical Manufacturing 92

Pharmaceutical Manufacturing Communication 92

Pharma Times

MAY 5, 2023

Systems will support millions of patients with chronic respiratory conditions throughout Europe

119

119

The Pharmacist

MAY 5, 2023

The World Health Organization (WHO) has declared that the global health emergency posed by Covid-19 is over – but stressed that the disease remained a ‘global health threat’. Dr Tedros Adhanom Ghebreyesus, director-general of the WHO said today that for over a year, the Covid-19 pandemic had been ‘on a downward trend’, due to population […] The post WHO declares Covid-19 global health emergency over appeared first on The Pharmacist.

88

88

pharmaphorum

MAY 5, 2023

Digitisation is fundamental to unlocking a patient-centric industry Mike.

120

120

The Pharmacist

MAY 5, 2023

Type 2 diabetes has been shown to cause lung disorders for the first time in a new study funded by Diabetes UK. In the largest-ever genetic study to explore how genes affect blood sugar levels and health outcomes, researchers from Imperial College London concluded that lung disorders should now be considered a complication of type […] The post Be alert to lung complications with type 2 diabetes, charity warns appeared first on The Pharmacist.

Diabetes 87

Diabetes 87

Express Pharma

MAY 5, 2023

The idea of green chemistry was initially developed as a response to the Pollution Prevention Act of 1990, which declared that US national policy should eliminate pollution by improved design including cost-effective changes in products, processes, use of raw materials, and recycling instead of treatment and disposal. The 12 Principles of Green Chemistry were published in 1998, providing the new field with a clear set of guidelines for further development.

Pharmaceutical Manufacturing 77

Pharmaceutical Manufacturing 77

Pharma Times

MAY 5, 2023

The vital recommendation ensures marketing authorisation for treating the hepatitis delta virus

97

97

Pharmaceutical Technology

MAY 5, 2023

TFF Pharmaceuticals and the National Institute of Environmental Health Sciences (NIEHS) have signed an agreement for the development of dry powder formulations of high molecular weight hyaluronan (HMW-HA) for respiratory diseases. Under the collaborative research and development agreement (CRADA), respirable dry powder formulations of HMW-HA will be developed for prevention and treatment.

Compounding 64

Compounding 64

BioPharma Dive

MAY 5, 2023

The medicine, available in Europe but rejected two years ago by U.S. regulators, didn’t eliminate the need for blood transfusions among patients with myelodysplastic syndrome.

59

59

Pharmaceutical Technology

MAY 5, 2023

The European Medicines Agency’s (EMA) committee for medicinal products for human use (CHMP) has recommended full marketing authorisation (MA) for Gilead Sciences ’ Hepcludex (bulevirtide) to treat chronic hepatitis delta virus (HDV) and compensated liver disease in adult patients. In July 2020, the European Commission (EC) granted conditional marketing authorisation to bulevirtide for urgent access to HDV treatment.

59

59

World Pharma News

MAY 5, 2023

Strategies to treat pain without triggering dangerous side effects such as euphoria and addiction have proven elusive. For decades, scientists have attempted to develop drugs that selectively activate one type of opioid receptor to treat pain while not activating another type of opioid receptor linked to addiction. Unfortunately, those compounds can cause a different unwanted effect: hallucinations.

Compounding 64

Compounding 64

Express Pharma

MAY 5, 2023

Neurodegeneration in brain cells may be happening when the natural cellular cleaning process malfunctions due to falling levels of a niacin-related coenzyme and leaves cells starved of energy, new research shows. Brain cells die from malfunction of autophagy, a process by which cells get rid of cellular waste and generate energy for their survival. In new research published in Cell Reports, researchers have found that a metabolic failure arising from loss of autophagy is detrimental to brain cel

Compounding 58

Compounding 58

Compounding Pharmacy of America

MAY 5, 2023

Women have been tracking their cycles for decades. Advanced at-home test kits now allow for easy hormone testing. Compounding Pharmacy of America explains. The post Understanding the Benefits of Menstrual Mapping appeared first on The Compounding Pharmacy of America.

Compounding Pharmacies 52

Compounding Pharmacies Compounding 52

The Honest Apothecary

MAY 5, 2023

There it is. Another meeting has been added to your calendar. Aren’t you excited? Probably not. But the fact is that meetings, when done well, are an effective and powerful tool to help your hospital achieve all their patient care goals. But are your meetings running well? They should be. In fact, the same concern we put into the quality of our patient care should apply to our concern for the quality of our meeting.

Hospitals 52

Hospitals Communication 52

Drug Patent Watch

MAY 5, 2023

Annual Drug Patent Expirations for PROAIR+DIGIHALER Proair Digihaler is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from one supplier. There are… The post New patent expiration for Teva Branded drug PROAIR DIGIHALER appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Fuld & Company Blog

MAY 5, 2023

Investment Banking Trends: Interest Rate Cycle Reversal Investment banking has experienced a decline in deal activity and volume, following a record-breaking 2021. The US Federal Reserve raised its benchmark interest rates, and other central banks followed suit, resulting in a fall in global M&A activity from over 60,000 transactions with a total deal value of over US$5.3t in 2021, to 10,000 fewer transactions in 2022 with a total deal value of just under US$3.3t.

52

52

Drug Patent Watch

MAY 5, 2023

Annual Drug Patent Expirations for PROAIR+RESPICLICK Proair Respiclick is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from one supplier. There are… The post New patent expiration for Teva Branded drug PROAIR RESPICLICK appeared first on DrugPatentWatch - Make Better Decisions.

52

52